Results of ARCADIA in Lancet (specifically eClinical Medicine journal which is part of Lancet)): A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19


The ARCADIA Trial – implications for therapeutic immune modulation – eClinicalMedicine

Read article here.